Oregon Public Employees Retirement Fund’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-6,819
| Closed | -$1.21M | – | 1548 |
|
|
2023
Q3 | $1.21M | Sell |
6,819
-3,309
| -33% | -$586K | 0.02% | 847 |
|
|
2023
Q2 | $1.92M | Sell |
10,128
-10,100
| -50% | -$1.92M | 0.02% | 642 |
|
|
2023
Q1 | $4.05M | Buy |
20,228
+208
| +1% | +$41.7K | 0.05% | 351 |
|
|
2022
Q4 | $4.76M | Buy |
+20,020
| New | +$4.76M | 0.06% | 318 |
|
|
2020
Q4 | – | Sell |
-15,500
| Closed | -$2.26M | – | 1604 |
|
|
2020
Q3 | $2.26M | Sell |
15,500
-800
| -5% | -$116K | 0.03% | 425 |
|
|
2020
Q2 | $2.41M | Sell |
16,300
-8,800
| -35% | -$1.3M | 0.04% | 407 |
|
|
2020
Q1 | $2.73M | Buy |
+25,100
| New | +$2.73M | 0.05% | 332 |
|
|
2018
Q2 | – | Sell |
-18,002
| Closed | -$2.14M | – | 1094 |
|
|
2018
Q1 | $2.14M | Buy |
18,002
+79
| +0.4% | +$9.41K | 0.03% | 568 |
|
|
2017
Q4 | $2.28M | Buy |
+17,923
| New | +$2.28M | 0.03% | 541 |
|
|
2016
Q3 | – | Sell |
-100
| Closed | -$6K | – | 927 |
|
|
2016
Q2 | $6K | Hold |
100
| – | – | ﹤0.01% | 1021 |
|
|
2016
Q1 | $6K | Hold |
100
| – | – | ﹤0.01% | 1017 |
|
|
2015
Q4 | $9K | Hold |
100
| – | – | ﹤0.01% | 1022 |
|
|
2015
Q3 | $8K | Hold |
100
| – | – | ﹤0.01% | 1022 |
|
|
2015
Q2 | $12K | Buy |
+100
| New | +$12K | ﹤0.01% | 1025 |
|